HUMAN FAECAL MATTER
Pre-Diabetes
Wiebke Kristin Fenskeother_biologicalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Pre-Diabetes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Empagliflozin The University of Texas Health Science Center at San Antonio | Phase 4 | BBB |
Phentermine University of Florida | Phase 2 | B |
Topamax University of Florida | Phase 2 | B |
Allopurinol University of Florida | Phase 2 | B |
Clindamycin University of Minnesota | Phase 2 | CCC |
View all 9 →
Same molecule, other indications
HUMAN FAECAL MATTER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →